The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
January 17th 2025
Semaglutide 7.2 mg achieved statistically significant and superior weight loss at 72 weeks versus placebo, hitting the Phase 3b trial's primary endpoint.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Cardiovascular Risk in Type 1 Diabetic Youths Linked Primarily to Insulin Resistance
December 2nd 2009Insulin resistance may affect long-term cardiovascular outcomes in type 1 diabetes and results indicate that insulin resistance is directly related to decreased heart and vessel function and appears to impair capacity to exercise.
Glucose Intolerance in Pregnancy Associated with Postpartum Cardiovascular Risk
December 2nd 2009Glucose intolerance during pregnancy predicts an increased likelihood of postpartum metabolic syndrome. In turn, cardiovascular risk factors at three months postpartum indicates that risk factors may be longstanding and contribute to long-term risk of cardiovascular disease.
Is the HITECH Act Unconstitutional? - Part 2
December 2nd 2009Some pundits have written that health insurance mandates are well beyond the constitutional authority of the federal government to tax, spend, and regulate interstate commerce. Others have picked up on these arguments and applied them to the EHR-implementation incentives under the HITECH Act as well. The bottom line is that these arguments fail, for four reasons.
Is the HITECH Act Unconstitutional? - Part 1
December 2nd 2009There has been much discussion about the HITECH Act and the effects it will have on healthcare in this country. The health IT industry and the federal government claim that EHR use will lead to a decrease in costs and an overall improvement in patient care. Skeptics like me disagree with these claims and feel that the push to adopt complex EHRs will be a bad deal for physicians.
Drug Therapy, Not Angioplasty, May Be Better Option for Patients with Diabetes and Heart Disease
November 30th 2009According to results from the National Institutes of Health Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) study, many patients with diabetes and heart disease may achieve better results with drug therapy instead of angioplasty.
Translating Education into Clinical Practice: The Role of Learning Communities
November 24th 2009Collaboration is important in healthcare, as evidenced by the growing number of "learning communities" and grassroots efforts that are bringing people and organizations together to work on the issue of eliminating disparities in health and healthcare.
Chronic Disease Improved with Interactive Games
November 16th 2009Researchers are finding that interactive game systems like Nintendo's Wii are especially helpful for people with chronic health conditions. Playing the games increases physical activity and can even improve the ability to care for oneself.
The pundits are going to have their field day with this one. "The danger [with this Bill] is that as costs continue to rise and coverage becomes less comprehensive, people will conclude that we've tried health reform and it didn't work. But the real problem will be that we didn't really try it.
AMA Wants Lawmakers to Regulate Endocrine-Disrupting Chemicals
November 11th 2009The AMA adopted a resolution calling on the federal government to enact new policies to decrease the public’s exposure to endocrine-disrupting chemicals through a single regulatory overseer to ensure coordination among agencies.
Rituximab Rapidly Improves Symptoms of Graves' Eye Disease
November 10th 2009Though researchers observed improvement among patients as early as four weeks following their first infusion, they caution that the results came from a small case series. However, given the substantial benefits for patients treated with rituximab, they see good reason to proceed with a large-scale clinical trial.
VA Grant Spurs Development of Therapy for Neuropathic Pain
November 10th 2009A $1.8 million grant will help the University of Michigan investigate the use of herpes simplex virus-based vectors to deliver genes to sensory nerves from application in the skin, which researchers believe hold promise not only for the treatment of pain but also ultimately for the treatment of peripheral neuropathy itself.